JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell StatesLaura E. Stevens, Kornélia Polyák, Jacqueline Salas et al.|Cancer Research|2022Cited by 101
Untangling the web of intratumour heterogeneityZheqi Li, Kornélia Polyák, Marco Seehawer|Nature Cell Biology|2022Cited by 82
Hotspot <i>ESR1</i> Mutations Are Multimodal and Contextual Modulators of Breast Cancer MetastasisZheqi Li, Steffi Oesterreich|Cancer Research|2022Cited by 80
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activationZheqi Li, Steffi Oesterreich|Nature Communications|2022Cited by 72
Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer CellsZheqi Li, Adrian V. Lee|Endocrinology|2017Cited by 45